Author(s): Mrunal M. Sabale, Varun A. Pande, Amol A. Tagalpallewar, Arti G. Swami, Anil T. Pawar, Akshay M. Baheti

Email(s): akshay.baheti@mitwpu.edu.in

DOI: 10.52711/0974-360X.2024.00381   

Address: Mrunal M. Sabale , Varun A. Pande , Amol A. Tagalpallewar , Arti G. Swami , Anil T. Pawar, Akshay M. Baheti*
School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 5,     Year - 2024


ABSTRACT:
In the pharma industry, data integrity (DI) is essential to make sure that the final products meet all the relevant quality requirements. It is the essence of all the methods of maintaining and ensuring the accuracy and continuity of data over its entire life cycle. DI is the most popular subject in the pharma industry. It gives precise, reliable and uniform data throughout its entire life cycle. This includes good documentation practices (GDP) that restrict the movement, deletion, copying or editing of data. Implementation of its principle will directly reflect the quality of the product. DI must comply with ALCOA+++ according to Food and Drug Administration (FDA) and Medicines and Healthcare Products Regulatory Agency (MHRA) guidelines. ALCOA+++ represents Attributable, Legible, Contemporary, Original, Accurate, Complete, Consistent, Enduring, Available. As outlined in numerous guidance and regulations, DI is over-critical to regulatory submissions. This article describes the concept, importance, regulatory requirements, data life cycle, types and principle ALCOA+++, DI-related risks, issues and its various solutions.


Cite this article:
Mrunal M. Sabale , Varun A. Pande , Amol A. Tagalpallewar , Arti G. Swami , Anil T. Pawar, Akshay M. Baheti. Maintaining Data safety and accuracy through Data Integrity (DI): A Comprehensive Review. Research Journal of Pharmacy and Technology. 2024; 17(5):2431-0. doi: 10.52711/0974-360X.2024.00381

Cite(Electronic):
Mrunal M. Sabale , Varun A. Pande , Amol A. Tagalpallewar , Arti G. Swami , Anil T. Pawar, Akshay M. Baheti. Maintaining Data safety and accuracy through Data Integrity (DI): A Comprehensive Review. Research Journal of Pharmacy and Technology. 2024; 17(5):2431-0. doi: 10.52711/0974-360X.2024.00381   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-5-77


REFERENCES:
1.    Choudhary A. Importance of Data Integrity in Pharmaceuticals. Available on https://www.pharmaguideline.com/2018/09/importance-of-data-integrity-inpharmaceuticals.html(accessed on 14 May 2021).
2.    Ahmad S., et al. Importance of DI and its Regulation in Pharmaceutical Industry. The Pharma Innovation Journal. 2019; 8(1): 306-13.
3.    Velimirovic A. What Is Data Integrity? Available on https://phoenixnap.com/blog/what-data-integrity(accessed on 10 May 2021).
4.    Bhadrashette MS. Overview of DI Issue in the Pharmaceutical Industry. International Journal of Pharmaceutical Sciences Review and Research. 2018; 50(2): 95-101.
5.    Charoo NA., et. al. DI Issues in Pharmaceutical Industry: Common Observations, Challenges and Mitigations Strategies. International Journal of Pharmaceutics. 2023; 631: 122503. doi:10.1016/j.ijpharm.2022.122503
6.    Rattan AK. Rattan A. K. (2018). Data Integrity: History, Issues, and Remediation of Issues. PDA Journal of Pharmaceutical Science and Technology. 2018; 72(2): 105-16. doi: https://doi.org/10.5731/pdajpst.2017.007765
7.    What Is Data Integrity and Why Is It Important? Available on https://www.talend.com/resources/what-is-data-integrity/ (accessed on 20 March 2021).
8.    What Is Data Integrity? Available on  https://database.guide/what-is-data-integrity/  (accessed on 20 March 2021).
9.    Data Integrity: The whole Story. Available on https://redica.com/data-integrity-the-whole-story/ (accessed on 20 March 2021).
10.    USP (2015) Good Documentation Guidelines. US Pharmacopeial Convention, USA.
11.    FDA (2016) Guidance to Industry “DI and Compliance with cGMP”. Food and Drug Administration, Rockville, USA, p. 1-13.
12.    Code of Federal Regulations- Title 21- Food and Drugs. Available on  https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Databases/ucm135680.htm
13.    The Electronic Code of Federal Regulations (eCFR). Available on https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?
14.    European Commission (2011) Good Manufacturing Practice Medicinal Products for Human and Veterinary Use. European Commission Health and Consumers Directorate-General, Chapter 4, Belgium 4: 1-9.
15.    Data Integrity: Key to Public Health Protection. Available on http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/08/news_detail_002589.jspandmid=WC0b01ac058004d5c1.
16.    ICH (2000) Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q7. International Conference on Harmonization, USA, 1-49.
17.    Agarwal P, Mishra A. Pharmaceutical Quality Audits: a Review. International Journal of Applied Pharmaceutics 2019;11(1):14-22.
18.    Jain SK. Strategy to Avoid DI Issues in the Pharmaceutical Industry. The Pharma Innovation Journal. 2017; 6(2): 110-5.
19.    Integrity in the Data Lifecycle. https://www.dataworks.ie/5-stages-in-the-data-management-lifecycle-process/ (accessed on 20 March 2021).
20.    Nikam NR, et. al. Data Integrity: An Overview. International Journal of Recent Scientific Research. 2020; 11(06A): 38762-7.
21.    Review of Good Data Integrity Principles. Available on https://www.ofnisystems.com/review-of-good-data-integrity-principles/ (accessed on 21 March 2021).
22.    Choudhary A. ALCOA in Pharmaceuticals: A Necessary Tool for Quality. Available on https://www.pharmaguideline.com/2017/05/alcoa-in-pharmaceuticals-necessary- tool.html?m=1 (accessed on 20 March 2021)
23.    How to Meet All 9 ALCOA Principles With Our Document Module. https://www.ideagen.com/thought-leadership/blog/how-to-meet-all-9-alcoa principles-with-   our-document-module  (accessed on 21 March 2021).
24.    Buckbee M. What Is Data Integrity and How Can You Maintain It? https://www.varonis.com/blog/data-integrity/  (accessed on 21 March 2021)
25.    DI in the Analytical Laboratory https://www.pharmtech.com/view/data-integrity-analytical-laboratory (accessed on 21 March 2021).
26.    Alosert H, et. al. Data Integrity Within the Biopharmaceutical Sector in the Era of Industry 4.0. Biotechnology Journal 2022;12:2100609. doi: 10.1002/biot.202100609
27.    Exploring Validation and Data Integrity in Pharma.http://www.pharmatimes.com/web_exclusives/exploring_validation_and_data_integrity_in_pharma_1246876#:~:text=Data%20integrity%20is%20absolutely%20critical,over%20its%20entire%20life%20cycle  (accessed on 21 March 2021)
28.    Ways to Ensure Data Integrity. https://www.vaisala.com/en/8-ways-ensure-data-integrity (accessed on 21 March 2021).
29.    https://redica.com/pharma-fda-sent-these-warning-letters-for-pharma-companies-august-2017/  (accessed on 25 March 2021)
30.    www.fda.gov; FDA’s Electronic Reading Room – Warning Letters

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available